| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | four-way junction DNA binding | 1.61e-04 | 19 | 20 | 2 | GO:0000400 | |
| GeneOntologyMolecularFunction | DNA binding, bending | 1.79e-04 | 20 | 20 | 2 | GO:0008301 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 3.55e-04 | 28 | 20 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 4.36e-04 | 31 | 20 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 4.64e-04 | 32 | 20 | 2 | GO:0140457 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 7.63e-04 | 41 | 20 | 2 | GO:0000217 | |
| GeneOntologyMolecularFunction | demethylase activity | 8.79e-04 | 44 | 20 | 2 | GO:0032451 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.47e-03 | 229 | 20 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 1.91e-03 | 65 | 20 | 2 | GO:0016706 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 2.73e-03 | 78 | 20 | 2 | GO:0003725 | |
| GeneOntologyMolecularFunction | rRNA binding | 2.80e-03 | 79 | 20 | 2 | GO:0019843 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 4.28e-03 | 98 | 20 | 2 | GO:0051213 | |
| GeneOntologyBiologicalProcess | positive regulation of hematopoietic progenitor cell differentiation | 3.20e-05 | 9 | 20 | 2 | GO:1901534 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 4.03e-05 | 1483 | 20 | 8 | GO:0048646 | |
| GeneOntologyBiologicalProcess | sensory organ development | 4.88e-05 | 730 | 20 | 6 | GO:0007423 | |
| GeneOntologyBiologicalProcess | eye development | 7.76e-05 | 480 | 20 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 7.99e-05 | 483 | 20 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 8.64e-05 | 491 | 20 | 5 | GO:0048880 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.11e-04 | 266 | 20 | 4 | GO:0045619 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.95e-04 | 343 | 20 | 4 | GO:0090596 | |
| GeneOntologyBiologicalProcess | myelin assembly | 3.33e-04 | 28 | 20 | 2 | GO:0032288 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 4.35e-04 | 32 | 20 | 2 | GO:0048596 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 5.20e-04 | 1125 | 20 | 6 | GO:0035239 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 5.75e-04 | 171 | 20 | 3 | GO:0048593 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 5.83e-04 | 37 | 20 | 2 | GO:0055075 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 6.15e-04 | 38 | 20 | 2 | GO:0048048 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 6.69e-04 | 426 | 20 | 4 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 6.86e-04 | 429 | 20 | 4 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 8.62e-04 | 45 | 20 | 2 | GO:0010464 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 8.62e-04 | 45 | 20 | 2 | GO:0031076 | |
| GeneOntologyBiologicalProcess | regulation of hematopoietic progenitor cell differentiation | 9.01e-04 | 46 | 20 | 2 | GO:1901532 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 9.60e-04 | 204 | 20 | 3 | GO:0048592 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.00e-03 | 207 | 20 | 3 | GO:0043484 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 1.11e-03 | 51 | 20 | 2 | GO:1990573 | |
| GeneOntologyBiologicalProcess | sprouting angiogenesis | 1.19e-03 | 220 | 20 | 3 | GO:0002040 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.29e-03 | 226 | 20 | 3 | GO:0045580 | |
| GeneOntologyBiologicalProcess | monocyte chemotaxis | 1.33e-03 | 56 | 20 | 2 | GO:0002548 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 1.34e-03 | 514 | 20 | 4 | GO:0050678 | |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 1.48e-03 | 59 | 20 | 2 | GO:0010463 | |
| GeneOntologyBiologicalProcess | regulation of vascular endothelial cell proliferation | 1.48e-03 | 59 | 20 | 2 | GO:1905562 | |
| GeneOntologyBiologicalProcess | vascular endothelial cell proliferation | 1.53e-03 | 60 | 20 | 2 | GO:0101023 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 1.58e-03 | 537 | 20 | 4 | GO:0030098 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 1.61e-03 | 540 | 20 | 4 | GO:1903706 | |
| GeneOntologyBiologicalProcess | tube development | 1.65e-03 | 1402 | 20 | 6 | GO:0035295 | |
| GeneOntologyBiologicalProcess | mononuclear cell migration | 1.88e-03 | 258 | 20 | 3 | GO:0071674 | |
| GeneOntologyBiologicalProcess | positive regulation of viral process | 2.02e-03 | 69 | 20 | 2 | GO:0048524 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte differentiation | 2.07e-03 | 70 | 20 | 2 | GO:0045620 | |
| GeneOntologyCellularComponent | costamere | 1.99e-04 | 22 | 20 | 2 | GO:0043034 | |
| MousePheno | turbinate hypoplasia | 9.38e-06 | 4 | 18 | 2 | MP:0004477 | |
| MousePheno | decreased lateral semicircular canal size | 3.28e-05 | 7 | 18 | 2 | MP:0003162 | |
| MousePheno | joint dislocation | 7.00e-05 | 10 | 18 | 2 | MP:0030795 | |
| MousePheno | abnormal turbinate morphology | 8.55e-05 | 11 | 18 | 2 | MP:0002244 | |
| MousePheno | abnormal olfactory bulb mitral cell layer morphology | 8.55e-05 | 11 | 18 | 2 | MP:0009951 | |
| MousePheno | abnormal crista ampullaris neuroepithelium morphology | 8.55e-05 | 11 | 18 | 2 | MP:0004409 | |
| MousePheno | abnormal pterygoid bone morphology | 1.03e-04 | 12 | 18 | 2 | MP:0004453 | |
| MousePheno | abnormal olfactory bulb glomerular layer morphology | 1.03e-04 | 12 | 18 | 2 | MP:0009948 | |
| MousePheno | short premaxilla | 1.21e-04 | 13 | 18 | 2 | MP:0000091 | |
| MousePheno | abnormal olfactory neuron innervation pattern | 1.21e-04 | 13 | 18 | 2 | MP:0012014 | |
| MousePheno | abnormal mandibular angle morphology | 1.63e-04 | 15 | 18 | 2 | MP:0004596 | |
| MousePheno | abnormal superior semicircular canal morphology | 1.86e-04 | 16 | 18 | 2 | MP:0003069 | |
| MousePheno | decreased cochlea coiling | 2.11e-04 | 17 | 18 | 2 | MP:0003148 | |
| MousePheno | abnormal mandibular condyloid process morphology | 2.11e-04 | 17 | 18 | 2 | MP:0004595 | |
| MousePheno | abnormal mandibular coronoid process morphology | 2.37e-04 | 18 | 18 | 2 | MP:0004594 | |
| MousePheno | abnormal olfactory nerve morphology | 2.37e-04 | 18 | 18 | 2 | MP:0005236 | |
| MousePheno | abnormal posterior semicircular canal morphology | 2.93e-04 | 20 | 18 | 2 | MP:0002858 | |
| MousePheno | meteorism | 2.93e-04 | 20 | 18 | 2 | MP:0009247 | |
| MousePheno | abnormal pterygoid process morphology | 3.24e-04 | 21 | 18 | 2 | MP:0004452 | |
| MousePheno | abnormal lateral semicircular canal morphology | 3.24e-04 | 21 | 18 | 2 | MP:0000037 | |
| MousePheno | abnormal olfactory bulb layer morphology | 3.56e-04 | 22 | 18 | 2 | MP:0009946 | |
| MousePheno | abnormal physiological neovascularization | 3.56e-04 | 22 | 18 | 2 | MP:0003710 | |
| MousePheno | abnormal mandibular ramus morphology | 3.90e-04 | 23 | 18 | 2 | MP:0010150 | |
| MousePheno | small premaxilla | 4.62e-04 | 25 | 18 | 2 | MP:0004870 | |
| MousePheno | abnormal crista ampullaris morphology | 5.80e-04 | 28 | 18 | 2 | MP:0004249 | |
| MousePheno | abnormal limb posture | 5.80e-04 | 28 | 18 | 2 | MP:0004263 | |
| MousePheno | abnormal maxillary shelf morphology | 6.23e-04 | 29 | 18 | 2 | MP:0004538 | |
| MousePheno | abnormal endolymphatic duct morphology | 7.12e-04 | 31 | 18 | 2 | MP:0006011 | |
| MousePheno | abnormal semicircular canal ampulla morphology | 7.59e-04 | 32 | 18 | 2 | MP:0008488 | |
| MousePheno | abnormal T cell compartment | 9.09e-04 | 35 | 18 | 2 | MP:0013887 | |
| MousePheno | abnormal T cell subpopulation ratio | 9.09e-04 | 35 | 18 | 2 | MP:0003944 | |
| MousePheno | abnormal metatarsal bone morphology | 9.61e-04 | 36 | 18 | 2 | MP:0003072 | |
| MousePheno | short maxilla | 1.13e-03 | 39 | 18 | 2 | MP:0000097 | |
| MousePheno | abnormal premaxilla morphology | 1.13e-03 | 39 | 18 | 2 | MP:0002820 | |
| MousePheno | impaired humoral immune response | 1.19e-03 | 40 | 18 | 2 | MP:0020154 | |
| MousePheno | abnormal Meckel's cartilage morphology | 1.25e-03 | 41 | 18 | 2 | MP:0005587 | |
| MousePheno | abnormal nasal septum morphology | 1.64e-03 | 47 | 18 | 2 | MP:0002239 | |
| MousePheno | abnormal olfactory epithelium morphology | 1.71e-03 | 48 | 18 | 2 | MP:0008789 | |
| MousePheno | abnormal ligament morphology | 1.78e-03 | 49 | 18 | 2 | MP:0005504 | |
| MousePheno | abnormal cranial cartilage morphology | 1.85e-03 | 50 | 18 | 2 | MP:0030464 | |
| MousePheno | abnormal palate bone morphology | 1.92e-03 | 51 | 18 | 2 | MP:0009891 | |
| MousePheno | abnormal axon morphology | 1.98e-03 | 199 | 18 | 3 | MP:0005404 | |
| MousePheno | abnormal neurite morphology | 2.12e-03 | 442 | 18 | 4 | MP:0008415 | |
| MousePheno | abnormal macrophage chemotaxis | 2.31e-03 | 56 | 18 | 2 | MP:0010760 | |
| MousePheno | abnormal olfactory system morphology | 2.31e-03 | 56 | 18 | 2 | MP:0005499 | |
| MousePheno | decreased interleukin-2 secretion | 2.40e-03 | 57 | 18 | 2 | MP:0008688 | |
| MousePheno | abnormal basisphenoid bone morphology | 2.40e-03 | 57 | 18 | 2 | MP:0000106 | |
| MousePheno | curly tail | 2.40e-03 | 57 | 18 | 2 | MP:0003051 | |
| MousePheno | abnormal nerve conduction | 2.57e-03 | 59 | 18 | 2 | MP:0005403 | |
| MousePheno | small maxilla | 2.57e-03 | 59 | 18 | 2 | MP:0004540 | |
| MousePheno | impaired limb coordination | 2.57e-03 | 59 | 18 | 2 | MP:0001524 | |
| MousePheno | abnormal semicircular canal morphology | 2.57e-03 | 59 | 18 | 2 | MP:0002428 | |
| MousePheno | abnormal head development | 2.83e-03 | 62 | 18 | 2 | MP:0012176 | |
| MousePheno | open neural tube | 2.84e-03 | 226 | 18 | 3 | MP:0000929 | |
| MousePheno | abnormal inner ear canal morphology | 2.92e-03 | 63 | 18 | 2 | MP:0002729 | |
| MousePheno | small lymph nodes | 2.92e-03 | 63 | 18 | 2 | MP:0002217 | |
| MousePheno | exencephaly | 2.99e-03 | 230 | 18 | 3 | MP:0000914 | |
| MousePheno | short mandible | 3.01e-03 | 64 | 18 | 2 | MP:0000088 | |
| MousePheno | distended abdomen | 3.10e-03 | 65 | 18 | 2 | MP:0001270 | |
| MousePheno | abnormal intervertebral disk morphology | 3.30e-03 | 67 | 18 | 2 | MP:0004173 | |
| MousePheno | abnormal hard palate morphology | 3.30e-03 | 67 | 18 | 2 | MP:0003756 | |
| MousePheno | abnormal symphysis morphology | 3.69e-03 | 71 | 18 | 2 | MP:0030877 | |
| MousePheno | abnormal cochlea morphology | 3.70e-03 | 248 | 18 | 3 | MP:0000031 | |
| MousePheno | abnormal nervous system development | 3.76e-03 | 1257 | 18 | 6 | MP:0003861 | |
| Domain | HMG_boxA_CS | 3.27e-06 | 3 | 20 | 2 | IPR017967 | |
| Domain | HMG_box | 2.38e-05 | 53 | 20 | 3 | PF00505 | |
| Domain | HMG | 2.52e-05 | 54 | 20 | 3 | SM00398 | |
| Domain | HMG_box_2 | 3.90e-05 | 9 | 20 | 2 | PF09011 | |
| Domain | HMG_box_dom | 4.40e-05 | 65 | 20 | 3 | IPR009071 | |
| Domain | HMG_BOX_1 | 4.88e-05 | 10 | 20 | 2 | PS00353 | |
| Domain | Znf_PHD-finger | 7.88e-05 | 79 | 20 | 3 | IPR019787 | |
| Domain | PHD | 1.12e-04 | 89 | 20 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.20e-04 | 91 | 20 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.36e-04 | 95 | 20 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.41e-04 | 96 | 20 | 3 | PS01359 | |
| Domain | JmjC | 2.96e-04 | 24 | 20 | 2 | PF02373 | |
| Domain | PDZ | 4.37e-04 | 141 | 20 | 3 | PF00595 | |
| Domain | Znf_FYVE_PHD | 4.94e-04 | 147 | 20 | 3 | IPR011011 | |
| Domain | PDZ | 5.03e-04 | 148 | 20 | 3 | SM00228 | |
| Domain | - | 5.24e-04 | 150 | 20 | 3 | 2.30.42.10 | |
| Domain | JMJC | 5.30e-04 | 32 | 20 | 2 | PS51184 | |
| Domain | JmjC_dom | 5.30e-04 | 32 | 20 | 2 | IPR003347 | |
| Domain | PDZ | 5.34e-04 | 151 | 20 | 3 | PS50106 | |
| Domain | PDZ | 5.44e-04 | 152 | 20 | 3 | IPR001478 | |
| Domain | JmjC | 5.64e-04 | 33 | 20 | 2 | SM00558 | |
| Domain | - | 1.18e-03 | 449 | 20 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.28e-03 | 459 | 20 | 4 | IPR013083 | |
| Domain | HMG_BOX_2 | 1.51e-03 | 54 | 20 | 2 | PS50118 | |
| Domain | - | 1.56e-03 | 55 | 20 | 2 | 1.10.30.10 | |
| Domain | PHD | 2.88e-03 | 75 | 20 | 2 | PF00628 | |
| Domain | TyrKc | 3.95e-03 | 88 | 20 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.95e-03 | 88 | 20 | 2 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.77e-03 | 97 | 20 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.77e-03 | 97 | 20 | 2 | IPR008266 | |
| Domain | Pkinase_Tyr | 8.29e-03 | 129 | 20 | 2 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.44e-03 | 138 | 20 | 2 | IPR001245 | |
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 21940993 | ||
| Pubmed | Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. | 1.06e-07 | 16 | 21 | 3 | 21745462 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 9598312 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 15007166 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20833135 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 4.81e-07 | 268 | 21 | 5 | 33024031 | |
| Pubmed | CUL4A-mediated ZEB1/microRNA-340-5p/HMGB1 axis promotes the development of osteoporosis. | 1.04e-06 | 3 | 21 | 2 | 37253097 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 31621076 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 17185750 | ||
| Pubmed | 3.43e-06 | 49 | 21 | 3 | 34368113 | ||
| Pubmed | HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. | 3.47e-06 | 5 | 21 | 2 | 19890330 | |
| Pubmed | 5.44e-06 | 57 | 21 | 3 | 18022353 | ||
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 7.28e-06 | 7 | 21 | 2 | 23415230 | |
| Pubmed | Proximity labeling reveals OTUD3 as a DNA-binding deubiquitinase of cGAS. | 9.27e-06 | 68 | 21 | 3 | 36966392 | |
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 8176201 | ||
| Pubmed | 1.36e-05 | 1429 | 21 | 7 | 35140242 | ||
| Pubmed | 1.43e-05 | 1440 | 21 | 7 | 30833792 | ||
| Pubmed | A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells. | 1.90e-05 | 11 | 21 | 2 | 14625392 | |
| Pubmed | 2.70e-05 | 13 | 21 | 2 | 24619213 | ||
| Pubmed | 4.15e-05 | 16 | 21 | 2 | 36418889 | ||
| Pubmed | 4.19e-05 | 330 | 21 | 4 | 21044950 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.29e-05 | 332 | 21 | 4 | 32786267 | |
| Pubmed | 4.64e-05 | 1153 | 21 | 6 | 29845934 | ||
| Pubmed | 4.70e-05 | 17 | 21 | 2 | 20808911 | ||
| Pubmed | 6.55e-05 | 20 | 21 | 2 | 16341224 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 7.24e-05 | 21 | 21 | 2 | 27626377 | |
| Pubmed | 7.96e-05 | 22 | 21 | 2 | 21384471 | ||
| Pubmed | A forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity. | 8.72e-05 | 23 | 21 | 2 | 22761313 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 9.93e-05 | 807 | 21 | 5 | 30575818 | |
| Pubmed | A chemical tool for blue light-inducible proximity photo-crosslinking in live cells. | 1.03e-04 | 25 | 21 | 2 | 35211260 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.09e-04 | 422 | 21 | 4 | 27342126 | |
| Pubmed | 1.21e-04 | 27 | 21 | 2 | 27178982 | ||
| Pubmed | Isolation and characterization of proteins associated with histone H3 tails in vivo. | 1.50e-04 | 30 | 21 | 2 | 17403666 | |
| Pubmed | 1.60e-04 | 31 | 21 | 2 | 23312518 | ||
| Pubmed | 1.60e-04 | 31 | 21 | 2 | 32546759 | ||
| Pubmed | Interaction proteomics of the HMGA chromatin architectural factors. | 1.70e-04 | 32 | 21 | 2 | 18850631 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 1.81e-04 | 33 | 21 | 2 | 26864203 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.17e-04 | 954 | 21 | 5 | 36373674 | |
| Pubmed | 2.75e-04 | 538 | 21 | 4 | 28524877 | ||
| Pubmed | 2.93e-04 | 217 | 21 | 3 | 34048709 | ||
| Pubmed | 3.24e-04 | 44 | 21 | 2 | 25010285 | ||
| Pubmed | 4.23e-04 | 1103 | 21 | 5 | 34189442 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 4.73e-04 | 621 | 21 | 4 | 22794259 | |
| Pubmed | 4.92e-04 | 259 | 21 | 3 | 31162944 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 5.10e-04 | 1149 | 21 | 5 | 35446349 | |
| Pubmed | 5.61e-04 | 271 | 21 | 3 | 26816005 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 5.82e-04 | 59 | 21 | 2 | 28813667 | |
| Pubmed | A cellular and spatial map of the choroid plexus across brain ventricles and ages. | 5.82e-04 | 59 | 21 | 2 | 33932339 | |
| Interaction | LHX2 interactions | 1.06e-06 | 183 | 21 | 5 | int:LHX2 | |
| Interaction | AHNAK interactions | 1.57e-05 | 318 | 21 | 5 | int:AHNAK | |
| Interaction | GJB7 interactions | 2.61e-05 | 56 | 21 | 3 | int:GJB7 | |
| Interaction | AGR2 interactions | 2.95e-05 | 934 | 21 | 7 | int:AGR2 | |
| Interaction | FEV interactions | 5.23e-05 | 203 | 21 | 4 | int:FEV | |
| Interaction | HNF1A interactions | 7.61e-05 | 80 | 21 | 3 | int:HNF1A | |
| Interaction | ISG15 interactions | 1.27e-04 | 494 | 21 | 5 | int:ISG15 | |
| Interaction | PRX interactions | 1.57e-04 | 18 | 21 | 2 | int:PRX | |
| Interaction | ATP6V1A interactions | 1.58e-04 | 270 | 21 | 4 | int:ATP6V1A | |
| Interaction | LHX1 interactions | 1.61e-04 | 103 | 21 | 3 | int:LHX1 | |
| Interaction | DNAAF2 interactions | 1.61e-04 | 103 | 21 | 3 | int:DNAAF2 | |
| Interaction | EN1 interactions | 1.96e-04 | 110 | 21 | 3 | int:EN1 | |
| Interaction | TERF2IP interactions | 2.14e-04 | 552 | 21 | 5 | int:TERF2IP | |
| Interaction | JSRP1 interactions | 2.15e-04 | 21 | 21 | 2 | int:JSRP1 | |
| Interaction | H3C1 interactions | 2.39e-04 | 901 | 21 | 6 | int:H3C1 | |
| Interaction | SP7 interactions | 2.48e-04 | 304 | 21 | 4 | int:SP7 | |
| Interaction | FOS interactions | 2.74e-04 | 312 | 21 | 4 | int:FOS | |
| Interaction | GTPBP1 interactions | 2.79e-04 | 124 | 21 | 3 | int:GTPBP1 | |
| Interaction | PAX7 interactions | 2.79e-04 | 124 | 21 | 3 | int:PAX7 | |
| Interaction | SUMO2 interactions | 2.94e-04 | 591 | 21 | 5 | int:SUMO2 | |
| Interaction | FLT3 interactions | 2.94e-04 | 318 | 21 | 4 | int:FLT3 | |
| Interaction | KLF8 interactions | 3.35e-04 | 329 | 21 | 4 | int:KLF8 | |
| Cytoband | 13q12 | 5.47e-05 | 24 | 21 | 2 | 13q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 2.99e-03 | 178 | 21 | 2 | chr7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q12 | 5.10e-03 | 234 | 21 | 2 | chr13q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 1.58e-02 | 422 | 21 | 2 | chr20q13 | |
| GeneFamily | Canonical high mobility group | 6.36e-05 | 11 | 20 | 2 | 511 | |
| GeneFamily | PHD finger proteins | 1.28e-04 | 90 | 20 | 3 | 88 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.16e-04 | 24 | 20 | 2 | 485 | |
| GeneFamily | PDZ domain containing | 5.98e-04 | 152 | 20 | 3 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.35e-02 | 161 | 20 | 2 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.90e-02 | 193 | 20 | 2 | 594 | |
| Coexpression | SU_PLACENTA | 1.77e-06 | 30 | 21 | 3 | M6349 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.71e-05 | 198 | 21 | 4 | M8624 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 1.74e-05 | 422 | 21 | 5 | M7396 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 2.22e-05 | 444 | 21 | 5 | MM1051 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 4.19e-05 | 854 | 21 | 6 | M1533 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 5.21e-05 | 888 | 21 | 6 | MM1018 | |
| Coexpression | LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR | 1.35e-04 | 126 | 21 | 3 | M39242 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS | 1.73e-04 | 137 | 21 | 3 | M41743 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 2.36e-04 | 152 | 21 | 3 | M39243 | |
| Coexpression | MARSON_FOXP3_TARGETS_STIMULATED_UP | 2.62e-04 | 30 | 21 | 2 | M3146 | |
| Coexpression | MARSON_FOXP3_TARGETS_STIMULATED_UP | 2.62e-04 | 30 | 21 | 2 | MM728 | |
| Coexpression | GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN | 3.50e-04 | 174 | 21 | 3 | M6501 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 3.68e-04 | 177 | 21 | 3 | M7632 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 4.53e-04 | 190 | 21 | 3 | M8457 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_3_DN | 4.68e-04 | 40 | 21 | 2 | M2169 | |
| Coexpression | GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP | 4.96e-04 | 196 | 21 | 3 | M3203 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP | 5.03e-04 | 197 | 21 | 3 | M3133 | |
| Coexpression | GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | 5.18e-04 | 199 | 21 | 3 | M8481 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 5.18e-04 | 199 | 21 | 3 | M3517 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_DN | 5.18e-04 | 199 | 21 | 3 | M9574 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 5.26e-04 | 200 | 21 | 3 | M8954 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 5.26e-04 | 200 | 21 | 3 | M9133 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP | 5.26e-04 | 200 | 21 | 3 | M9522 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 5.26e-04 | 200 | 21 | 3 | M6057 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP | 5.26e-04 | 200 | 21 | 3 | M9584 | |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_UP | 5.49e-04 | 203 | 21 | 3 | M9695 | |
| Coexpression | PARENT_MTOR_SIGNALING_DN | 5.67e-04 | 44 | 21 | 2 | M16644 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_1_DN | 6.19e-04 | 46 | 21 | 2 | M2161 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.42e-08 | 200 | 20 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.42e-08 | 200 | 20 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.19e-06 | 182 | 20 | 4 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.19e-06 | 182 | 20 | 4 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 1.27e-06 | 185 | 20 | 4 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 1.33e-06 | 187 | 20 | 4 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.48e-06 | 192 | 20 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-06 | 193 | 20 | 4 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-06 | 193 | 20 | 4 | aaf681f16f310168e4719464814a1fc0a2f8431a | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-06 | 194 | 20 | 4 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-06 | 196 | 20 | 4 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-06 | 196 | 20 | 4 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.67e-06 | 198 | 20 | 4 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-06 | 199 | 20 | 4 | 59915b6db86fd0cc83a0bf9a3a1dda08522ec8d3 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-06 | 199 | 20 | 4 | 307d29816a224193aa3d8c4540e128b2ad2e90b9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-06 | 200 | 20 | 4 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.74e-06 | 200 | 20 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-06 | 200 | 20 | 4 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.74e-06 | 200 | 20 | 4 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.74e-06 | 200 | 20 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.74e-06 | 200 | 20 | 4 | 0242d465da2dfba0da629a43e152949c5192465b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 159 | 20 | 3 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.81e-05 | 160 | 20 | 3 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 164 | 20 | 3 | 1592a5becad7e0f3f990f0d7581d75fcfc7da023 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 5.47e-05 | 167 | 20 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 5.56e-05 | 168 | 20 | 3 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 5.56e-05 | 168 | 20 | 3 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 169 | 20 | 3 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 5.86e-05 | 171 | 20 | 3 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 173 | 20 | 3 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 173 | 20 | 3 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.17e-05 | 174 | 20 | 3 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-05 | 176 | 20 | 3 | dc5a22f9d1347f157bdd93e6e5769b983deccf1a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-05 | 176 | 20 | 3 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 177 | 20 | 3 | 7853430fb0d1a18d835e8956777e0616c5d7d412 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 177 | 20 | 3 | 395f005f019aabb18738d3a10a04c37f216deda3 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 177 | 20 | 3 | 9a5bf67a801826d094f679dd2189b62296c9694f | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.61e-05 | 178 | 20 | 3 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | Endothelial-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 6.72e-05 | 179 | 20 | 3 | 138fd6ba6bdbd0ad01c574168addf720b67a0fea | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.83e-05 | 180 | 20 | 3 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.83e-05 | 180 | 20 | 3 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.83e-05 | 180 | 20 | 3 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.83e-05 | 180 | 20 | 3 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 180 | 20 | 3 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.94e-05 | 181 | 20 | 3 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 181 | 20 | 3 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.06e-05 | 182 | 20 | 3 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.06e-05 | 182 | 20 | 3 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.06e-05 | 182 | 20 | 3 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 7.06e-05 | 182 | 20 | 3 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 7.06e-05 | 182 | 20 | 3 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 7.41e-05 | 185 | 20 | 3 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 7.41e-05 | 185 | 20 | 3 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-05 | 185 | 20 | 3 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.41e-05 | 185 | 20 | 3 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 7.41e-05 | 185 | 20 | 3 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-05 | 185 | 20 | 3 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 7.53e-05 | 186 | 20 | 3 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.53e-05 | 186 | 20 | 3 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.53e-05 | 186 | 20 | 3 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-05 | 187 | 20 | 3 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-05 | 187 | 20 | 3 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.65e-05 | 187 | 20 | 3 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.65e-05 | 187 | 20 | 3 | 60f41b1f1b656d211b80398aa2cf0ac0cdad9372 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 7.65e-05 | 187 | 20 | 3 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-05 | 187 | 20 | 3 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.65e-05 | 187 | 20 | 3 | d543ddc63f864b6d0982c4ff652af174af085c4a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-05 | 187 | 20 | 3 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 7.77e-05 | 188 | 20 | 3 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 7.77e-05 | 188 | 20 | 3 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-05 | 188 | 20 | 3 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 7.77e-05 | 188 | 20 | 3 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 7.77e-05 | 188 | 20 | 3 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.89e-05 | 189 | 20 | 3 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 7.89e-05 | 189 | 20 | 3 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-05 | 189 | 20 | 3 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.89e-05 | 189 | 20 | 3 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 7.89e-05 | 189 | 20 | 3 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 7.89e-05 | 189 | 20 | 3 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 7.89e-05 | 189 | 20 | 3 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.89e-05 | 189 | 20 | 3 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.02e-05 | 190 | 20 | 3 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.02e-05 | 190 | 20 | 3 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 8.02e-05 | 190 | 20 | 3 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 8.02e-05 | 190 | 20 | 3 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 8.02e-05 | 190 | 20 | 3 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.02e-05 | 190 | 20 | 3 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 8.02e-05 | 190 | 20 | 3 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.02e-05 | 190 | 20 | 3 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.14e-05 | 191 | 20 | 3 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 8.14e-05 | 191 | 20 | 3 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.14e-05 | 191 | 20 | 3 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 8.14e-05 | 191 | 20 | 3 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.14e-05 | 191 | 20 | 3 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.14e-05 | 191 | 20 | 3 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.14e-05 | 191 | 20 | 3 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.27e-05 | 192 | 20 | 3 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 8.27e-05 | 192 | 20 | 3 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-05 | 192 | 20 | 3 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.27e-05 | 192 | 20 | 3 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.17e-05 | 12 | 21 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Kawasaki disease (is_marker_for) | 4.37e-05 | 14 | 21 | 2 | DOID:13378 (is_marker_for) | |
| Disease | Sezary Syndrome | 1.68e-04 | 27 | 21 | 2 | C0036920 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 2.36e-04 | 32 | 21 | 2 | DOID:332 (is_implicated_in) | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.67e-04 | 34 | 21 | 2 | EFO_0009926 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 4.28e-04 | 43 | 21 | 2 | DOID:9261 (is_marker_for) | |
| Disease | Alzheimer disease, age at onset | 1.77e-03 | 343 | 21 | 3 | EFO_0004847, MONDO_0004975 | |
| Disease | hypertrophic cardiomyopathy | 1.94e-03 | 92 | 21 | 2 | EFO_0000538 | |
| Disease | Squamous cell carcinoma of esophagus | 2.07e-03 | 95 | 21 | 2 | C0279626 | |
| Disease | angina pectoris | 3.55e-03 | 125 | 21 | 2 | EFO_0003913 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKGPKFKMPEMNIKV | 801 | Q09666 | |
| EGKLKGPKFKMPEMN | 926 | Q09666 | |
| GPKFKMPEMNIKAPK | 931 | Q09666 | |
| IKMPKFSMPSLKGEG | 1001 | Q09666 | |
| PEGKLKGPKFKMPEM | 1046 | Q09666 | |
| GKLKGPKFKMPEMHF | 1176 | Q09666 | |
| DAKLKGPKFKMPEMS | 1431 | Q09666 | |
| PKVKMPKFSMPGFKG | 1511 | Q09666 | |
| KLKGPKFKMPSMNIQ | 1561 | Q09666 | |
| PDAKLKGPKFKMPDM | 1901 | Q09666 | |
| KGPKFKMPDMHFKAP | 1906 | Q09666 | |
| KLKGPKFKMPEMHFK | 1971 | Q09666 | |
| KGPKLKMPEMHFKAP | 2101 | Q09666 | |
| KLKGPKFKMPEMHFK | 2166 | Q09666 | |
| MKMPKFSMPGFKGEG | 2246 | Q09666 | |
| PEGKLKGPKFKMPEM | 2291 | Q09666 | |
| KLKGPKLKMPEMNIK | 2561 | Q09666 | |
| PEGKLKGPKFKMPEM | 2686 | Q09666 | |
| KGPKFKMPEMNIKAP | 2691 | Q09666 | |
| LKGPKFKMPEMNIKA | 2946 | Q09666 | |
| EGKLKGPKFKMPEMN | 3071 | Q09666 | |
| GPKFKMPEMNIKAPK | 3076 | Q09666 | |
| KLKGPKFKMPEMNIK | 3201 | Q09666 | |
| MPDLDLNLKGPKMKG | 3221 | Q09666 | |
| LKGPKFKMPDMNIKA | 3526 | Q09666 | |
| DAKLKGPKFKMPEMN | 3651 | Q09666 | |
| GPKFKMPEMNIKAPK | 3656 | Q09666 | |
| KVKMPKFSMPGFKGE | 3806 | Q09666 | |
| LKGPKFKMPEMNIKA | 3856 | Q09666 | |
| DAKLKGPKFKMPEMN | 3981 | Q09666 | |
| GPKFKMPEMNIKAPK | 3986 | Q09666 | |
| PKVKMPKFSMPGFKG | 4061 | Q09666 | |
| MPEVDLNLKGPKMKG | 4131 | Q09666 | |
| PDAKLKGPKFKMPEM | 4236 | Q09666 | |
| KGPKFKMPEMNIKAP | 4241 | Q09666 | |
| AKLKGPKFKMPEMNI | 4366 | Q09666 | |
| KLKGPKFKMPEMNIK | 4441 | Q09666 | |
| DAKLKGPKFKMPEMS | 4701 | Q09666 | |
| PKVKMPKFSMPGFKG | 4781 | Q09666 | |
| KIKKIMKNGEMPPEH | 191 | P56178 | |
| FKDKTMLCPMHKPKG | 4496 | Q8NEZ4 | |
| MGKGDPKKPRGKMSS | 1 | P09429 | |
| PGPKMMGLGLMAKDK | 241 | Q9BY66 | |
| KPGGILMMDLKEEKP | 81 | Q15165 | |
| KDMKKFGGPGRMKQS | 631 | Q8NHM5 | |
| EMNPMKKKILAAKGG | 416 | Q12860 | |
| KMAAEAGKKQPGMKP | 46 | Q8NFQ5 | |
| MAKGDPKKPKGKMSA | 1 | O15347 | |
| KKKPTKTPQMGTFMG | 176 | Q9UHW9 | |
| PGPGGDMAAKMSKKK | 16 | P20648 | |
| YMMPAKGKKTDKQPL | 916 | Q9P2J5 | |
| MGKGDPKKPRGKMSS | 1 | B2RPK0 | |
| MPKVALKGPQMDVKG | 1751 | Q8IVF2 | |
| GKEMKEKTQRMKQPP | 286 | Q63HN8 | |
| GQKPYKKMKGPEVMA | 536 | P43403 | |
| CMKLGKKPMYKPVDP | 81 | O95793 | |
| EFGFKMPKMTMPKLG | 796 | Q9BXM0 | |
| PPKKKMRKTENGMYA | 891 | P37275 | |
| KKEKMEPGLEQGKKP | 941 | P17948 |